SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001485003-18-000064
Filing Date
2018-05-16
Accepted
2018-05-15 21:23:40
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3/A ebio-formsx3auniversalshel.htm S-3/A 459521
2 EXHIBIT 5.1 ebio-exhibit51opinion2018s.htm EX-5.1 32293
3 EXHIBIT 23.1 ex231-consentforformsx3a1d.htm EX-23.1 2493
4 ebioexhibit51opinion.jpg GRAPHIC 28105
5 ebioforms3auniversals_image1.jpg GRAPHIC 3986
  Complete submission text file 0001485003-18-000064.txt   539630
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-223750 | Film No.: 18838653
SIC: 2834 Pharmaceutical Preparations